Status:
COMPLETED
CTRP3 and Progranulin in Patients With Coronary Artery Disease
Lead Sponsor:
Korea University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
20-80 years
Brief Summary
Visceral obesity is the one of the major causes of cardiovascular morbidity and mortality in industrialized countries. Adipose tissue secretes various kinds of bioactive molecules termed adipokines wh...
Detailed Description
CTRP-3 (synonyms CORS-26, cartducin and cartonectin) is a potent anti-inflammatory adipokine that inhibits proinflammatory pathways in monocytes and adipocytes. Using a recently developed enzymelinked...
Eligibility Criteria
Inclusion
- acute myocardial infarction
- unstable angina
- stable angina pectoris
Exclusion
- For control group, we exclude the participants who had
- a history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization)
- type 2 diabetes
- stage 2 hypertension (resting blood pressure, ≥160/100 mmHg)
- malignancy
- severe renal or hepatic disease
Key Trial Info
Start Date :
March 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2012
Estimated Enrollment :
362 Patients enrolled
Trial Details
Trial ID
NCT01869816
Start Date
March 1 2011
End Date
December 31 2012
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital Dept. of Endocrinology
Seoul, South Korea